Circulating Nucleic Acids and Diabetic Complications
Asif N. Butt(St Thomas' Hospital), R. Swaminathan(King's College London), Zaid Shalchi(Moorfields Eye Hospital NHS Foundation Trust), ANDJENY SAMADHAN(St Thomas' Hospital), Jake Powrie(Guy's and St Thomas' NHS Foundation Trust), S A Smith(St Thomas' Hospital), Sarah Janikoun(St Thomas' Hospital), Karim Hamaoui(St Thomas' Hospital)
Cited by 21
Related Papers
Blood and Islet Phenotypes Indicate Immunological Heterogeneity in Type 1 Diabetes
|Diabetes|2014|244
Worldwide comparison of survival from childhood leukaemia for 1995–2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89 828 children from 198 registries in 53 countries
|The Lancet Haematology|2017|216
Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes
|Science Translational Medicine|2017|215
Peripheral and Islet Interleukin-17 Pathway Activation Characterizes Human Autoimmune Diabetes and Promotes Cytokine-Mediated β-Cell Death
|Diabetes|2011|213
Self‐monitoring in Type 2 diabetes mellitus: a meta‐analysis
|Diabetic Medicine|2000|177